{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:21:32Z","timestamp":1791073292235,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.prrv.2007.02.009","type":"journal-article","created":{"date-parts":[[2007,3,22]],"date-time":"2007-03-22T11:00:49Z","timestamp":1174561249000},"page":"24-29","source":"Crossref","is-referenced-by-count":147,"title":["Mucolytics in cystic fibrosis"],"prefix":"10.1016","volume":"8","author":[{"given":"Markus O.","family":"Henke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Ratjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prrv.2007.02.009_bib1","doi-asserted-by":"crossref","first-page":"71S","DOI":"10.1378\/chest.107.2_Supplement.71S","article-title":"Pharmacological treatment of abnormal ion transport in the airway epithelium in cystic fibrosis","volume":"107","author":"Knowles","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2007.02.009_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00010.2005","article-title":"Respiratory tract mucin genes and mucin glycoproteins in health and disease","volume":"86","author":"Rose","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.prrv.2007.02.009_bib3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1165\/rcmb.2003-0345OC","article-title":"MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions","volume":"31","author":"Henke","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.prrv.2007.02.009_bib4","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.200607-1011OC","article-title":"MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation","author":"Henke","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2007.02.009_bib5","series-title":"Acute respiratory failure in chronic obstructive lung disease","first-page":"391","article-title":"Mucus physiology and pathophysiology: Therapeutic aspects","author":"Rubin","year":"1996"},{"key":"10.1016\/j.prrv.2007.02.009_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0003-9861(76)90419-7","article-title":"Human respiratory tract secretion. Mucous glycoproteins of nonpurulent tracheobronchial secretions, and sputum of patients with bronchitis and cystic fibrosis","volume":"177","author":"Boat","year":"1976","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.prrv.2007.02.009_bib7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/jama.232.12.1243","article-title":"Chronic obstructive airway diseases. Current concepts in diagnosis and comprehensive care","volume":"232","author":"Hodgkin","year":"1975","journal-title":"JAMA"},{"key":"10.1016\/j.prrv.2007.02.009_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0091-6749(90)90147-V","article-title":"Pathogenesis of airway mucus hypersecretion","volume":"85","author":"Lundgren","year":"1990","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.prrv.2007.02.009_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000196486","article-title":"Physical and functional properties of airway secretions in cystic fibrosis\u2014therapeutic approaches","volume":"62","author":"Puchelle","year":"1995","journal-title":"Respiration"},{"key":"10.1016\/j.prrv.2007.02.009_bib10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1378\/chest.129.1.118","article-title":"Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis","volume":"129","author":"Bush","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2007.02.009_bib11","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1378\/chest.128.5.3699","article-title":"An in vitro evaluation of the effectiveness of endotracheal suction catheters","volume":"128","author":"Shah","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2007.02.009_bib12","first-page":"341","article-title":"Physical properties of sputum. VII. Rheologic properties and mucociliary transport","volume":"112","author":"Dulfano","year":"1975","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.prrv.2007.02.009_bib13","first-page":"553","article-title":"Mucociliary transference rate and mucus viscoelasticity dependence on dynamic storage and loss modulus","volume":"120","author":"Gelman","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.prrv.2007.02.009_bib14","first-page":"721","article-title":"The in vitro reduction in viscosity of human tracheobronchial secretions by acetylcysteine","volume":"90","author":"Sheffner","year":"1964","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.prrv.2007.02.009_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archotol.125.1.101","article-title":"Effects of mucokinetic drugs on rheological properties of reconstituted human nasal mucus","volume":"125","author":"Rhee","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.prrv.2007.02.009_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00606662","article-title":"Pharmacokinetics of N-acetylcysteine in man","volume":"31","author":"Borgstrom","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl","key":"10.1016\/j.prrv.2007.02.009_bib17","first-page":"45","article-title":"Toxicological, pharmacokinetic and metabolic studies on acetylcysteine","volume":"111","author":"Bonanomi","year":"1980","journal-title":"Eur J Respir Dis"},{"key":"10.1016\/j.prrv.2007.02.009_bib18","first-page":"73","article-title":"No penetration of orally administered N-acetylcysteine into bronchoalveolar lavage fluid","volume":"70","author":"Cotgreave","year":"1987","journal-title":"Eur J Respir Dis"},{"key":"10.1016\/j.prrv.2007.02.009_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/thx.46.1.39","article-title":"Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine","volume":"46","author":"Bridgeman","year":"1991","journal-title":"Thorax"},{"key":"10.1016\/j.prrv.2007.02.009_bib20","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","article-title":"Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial","volume":"365","author":"Decramer","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.prrv.2007.02.009_bib21","first-page":"405","article-title":"Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases","volume":"64","author":"Boman","year":"1983","journal-title":"Eur J Respir Dis"},{"issue":"Suppl","key":"10.1016\/j.prrv.2007.02.009_bib22","first-page":"65","article-title":"Multicenter, double-blind study of oral acetylcysteine vs. placebo","volume":"111","author":"Brocard","year":"1980","journal-title":"Eur J Respir Dis"},{"key":"10.1016\/j.prrv.2007.02.009_bib23","first-page":"131","article-title":"Influence of tasuldine and acetylcysteine on mucociliary clearance in patients with chronic airways obstruction","volume":"36","author":"Dorow","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.prrv.2007.02.009_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0954-6111(06)80220-9","article-title":"N-acetylcysteine by metered dose inhaler in the treatment of chronic bronchitis: a multi-centre study","volume":"86","author":"Dueholm","year":"1992","journal-title":"Respir Med"},{"key":"10.1016\/j.prrv.2007.02.009_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00606554","article-title":"A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis","volume":"09","author":"Grassi","year":"1976","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.prrv.2007.02.009_bib26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0954-6111(05)80337-3","article-title":"Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis","volume":"88","author":"Hansen","year":"1994","journal-title":"Respir Med"},{"key":"10.1016\/j.prrv.2007.02.009_bib27","unstructured":"Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee. Thorax 1985; 40: 832\u2013835."},{"key":"10.1016\/j.prrv.2007.02.009_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/030006058401200206","article-title":"Irish general practice study of acetylcysteine (Fabrol) in chronic bronchitis","volume":"12","author":"Tattersall","year":"1984","journal-title":"J Int Med Res"},{"key":"10.1016\/j.prrv.2007.02.009_bib29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.03.00063402","article-title":"N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease","volume":"21","author":"Gerrits","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2007.02.009_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2466-4-13","article-title":"Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease","volume":"4","author":"Black","year":"2004","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.prrv.2007.02.009_bib31","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.0511304103","article-title":"High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis","volume":"103","author":"Tirouvanziam","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.prrv.2007.02.009_bib32","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","article-title":"Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum","volume":"87","author":"Shak","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.prrv.2007.02.009_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/thx.51.2.119","article-title":"In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis","volume":"51","author":"Shah","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.prrv.2007.02.009_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1164\/ajrccm.154.2.8756815","article-title":"Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability","volume":"154","author":"Wills","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2007.02.009_bib35","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1164\/rccm.200307-959OC","article-title":"Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis","volume":"169","author":"Paul","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2007.02.009_bib36","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jama.267.14.1947","article-title":"Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study","volume":"267","author":"Aitken","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.prrv.2007.02.009_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1378\/chest.108.1.153","article-title":"Comparison of three jet nebulizer aerosol delivery systems used to administer recombinant human DNase I to patients with cystic fibrosis. The Pulmozyme rhDNase Study Group","volume":"108","author":"Fiel","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2007.02.009_bib38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2007.02.009_bib39","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1378\/chest.110.4.889","article-title":"Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group","volume":"110","author":"McCoy","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2007.02.009_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ppul.20134","article-title":"DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: Influence of treatment with dornase alpha","volume":"39","author":"Ratjen","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2007.02.009_bib41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1067\/mpd.2001.118570","article-title":"A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities","volume":"139","author":"Quan","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.prrv.2007.02.009_bib42","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1378\/chest.128.4.2327","article-title":"Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysis","volume":"128","author":"Robinson","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2007.02.009_bib43","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1164\/ajrccm.153.6.8665055","article-title":"Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations","volume":"153","author":"Wilmott","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2007.02.009_bib44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ppul.1950170613","article-title":"Consensus conference: practical applications of Pulmozyme. September 22, 1993","volume":"17","author":"Ramsey","year":"1994","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2007.02.009_bib45","first-page":"919","article-title":"Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease","volume":"148","author":"Sheils","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.prrv.2007.02.009_bib46","series-title":"Cilia, mucus, and mucociliary interactions","first-page":"333","article-title":"DNA and actin filaments ultrastructure in cystic fibrosis sputum","author":"Tomkiewicz","year":"1998"},{"key":"10.1016\/j.prrv.2007.02.009_bib47","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1126\/science.8310295","article-title":"Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin","volume":"263","author":"Vasconcellos","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.prrv.2007.02.009_bib48","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.biophys.29.1.545","article-title":"Molecular mechanisms controlling actin filament dynamics in nonmuscle cells","volume":"29","author":"Pollard","year":"2000","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"10.1016\/j.prrv.2007.02.009_bib49","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1378\/chest.130.5.1433","article-title":"Thymosin beta4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro","volume":"130","author":"Rubin","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2007.02.009_bib50","series-title":"Advances in physiological fluid dynamics","first-page":"74","article-title":"Rheological properties in cystic fibrosis and airway secretions with combined rhDNase and gelsolin treatment","author":"Dasgupta","year":"1996"},{"key":"10.1016\/j.prrv.2007.02.009_bib51","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","article-title":"Mucus clearance and lung function in cystic fibrosis with hypertonic saline","volume":"354","author":"Donaldson","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2007.02.009_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2007.02.009_bib53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1056\/NEJMe058293","article-title":"Restoring airway surface liquid in cystic fibrosis","volume":"354","author":"Ratjen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2007.02.009_bib54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1164\/ajrccm.156.1.9512074","article-title":"Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I","volume":"156","author":"King","year":"1997","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054207000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054207000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T14:47:28Z","timestamp":1556290048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054207000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S1526054207000103"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2007.02.009","relation":{},"ISSN":["1526-0542"],"issn-type":[{"value":"1526-0542","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}